Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Income from Continuing Operations (2018 - 2025)

Historic Income from Continuing Operations for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$59.1 million.

  • Bicycle Therapeutics' Income from Continuing Operations fell 1633.4% to -$59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.4 million, marking a year-over-year decrease of 5384.15%. This contributed to the annual value of -$174.8 million for FY2024, which is 348.97% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Income from Continuing Operations of -$59.1 million as of Q3 2025, which was down 1633.4% from -$79.0 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Income from Continuing Operations peaked at -$14.7 million during Q3 2021, and registered a low of -$79.0 million during Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' median Income from Continuing Operations value was -$39.1 million (recorded in 2023), while the average stood at -$39.1 million.
  • As far as peak fluctuations go, Bicycle Therapeutics' Income from Continuing Operations surged by 3212.93% in 2024, and later plummeted by 12909.89% in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Income from Continuing Operations (Quarter) stood at -$19.1 million in 2021, then tumbled by 94.02% to -$37.0 million in 2022, then plummeted by 34.01% to -$49.6 million in 2023, then fell by 16.31% to -$57.6 million in 2024, then fell by 2.52% to -$59.1 million in 2025.
  • Its Income from Continuing Operations was -$59.1 million in Q3 2025, compared to -$79.0 million in Q2 2025 and -$60.7 million in Q1 2025.